RTOG-0834

Closed to Accrual & Treatment

Return to Protocol Table

Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma: The CATNON Intergroup Trial

Principal Investigator

Michael Vogelbaum, MD, PhD

Status

Closed to Accrual & Treatment

Date Opened To Accrual

July 22 2009

Date Closed to Accrual

September 16 2015

Disease Site

Brain [BN]

Benign Brain Tumors

Phase

III

Developmental Therapeutics

Primary Objective

Patient Population

Target Accrual

748

Protocol Documents

Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.